Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-26

FDA Approved: MEFLOQUINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for mefloquine hydrochloride from Chartwell RX, LLC (ANDA 076175).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mefloquine hydrochloride (Mefloquine hydrochloride)

Snippet

SUPPL AP for MEFLOQUINE HYDROCHLORIDE (MEFLOQUINE HYDROCHLORIDE)